- Home
- HOMB vs LEGN Comparison
HOMB vs LEGN Comparison
Compare HOMB & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOMB
- LEGN
- Stock Information
- Founded
- HOMB 1998
- LEGN 2014
- Country
- HOMB United States
- LEGN United States
- Employees
- HOMB N/A
- LEGN N/A
- Industry
- HOMB Major Banks
- LEGN Biotechnology: Pharmaceutical Preparations
- Sector
- HOMB Finance
- LEGN Health Care
- Exchange
- HOMB Nasdaq
- LEGN Nasdaq
- Market Cap
- HOMB 5.0B
- LEGN 5.4B
- IPO Year
- HOMB 2006
- LEGN 2020
- Fundamental
- Price
- HOMB $29.48
- LEGN $38.96
- Analyst Decision
- HOMB Hold
- LEGN Strong Buy
- Analyst Count
- HOMB 5
- LEGN 12
- Target Price
- HOMB $31.00
- LEGN $73.91
- AVG Volume (30 Days)
- HOMB 1.0M
- LEGN 1.6M
- Earning Date
- HOMB 07-16-2025
- LEGN 08-08-2025
- Dividend Yield
- HOMB 2.66%
- LEGN N/A
- EPS Growth
- HOMB 8.29
- LEGN N/A
- EPS
- HOMB 2.09
- LEGN N/A
- Revenue
- HOMB $987,214,000.00
- LEGN $728,303,000.00
- Revenue This Year
- HOMB $11.25
- LEGN $65.49
- Revenue Next Year
- HOMB $2.78
- LEGN $53.76
- P/E Ratio
- HOMB $14.04
- LEGN N/A
- Revenue Growth
- HOMB 1.15
- LEGN 112.46
- 52 Week Low
- HOMB $24.22
- LEGN $27.34
- 52 Week High
- HOMB $32.91
- LEGN $60.87
- Technical
- Relative Strength Index (RSI)
- HOMB 59.04
- LEGN 66.26
- Support Level
- HOMB $29.22
- LEGN $34.64
- Resistance Level
- HOMB $29.98
- LEGN $39.88
- Average True Range (ATR)
- HOMB 0.54
- LEGN 1.46
- MACD
- HOMB 0.12
- LEGN 0.37
- Stochastic Oscillator
- HOMB 77.92
- LEGN 87.67
About HOMB Home BancShares Inc.
Home BancShares Inc is a bank holding company that operates through its wholly owned community bank subsidiary, Centennial Bank. The bank provides a broad range of commercial and retail banking, as well as related financial services, to a diverse customer base. Its customer base includes businesses, real estate developers and investors, individuals, and municipalities. The company's loan portfolio, while diversified, is typically between half and two thirds in commercial real estate loans. The company's plan emphasizes growth, both through strategic acquisitions and organically within its existing markets. The bank also emphasizes attracting experienced bankers, credit quality and a solid balance sheet. The bank's main source of net revenue is net interest income.
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.